Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectors

Nanoparticle-mediated siRNA delivery is a promising therapeutic approach, however, the processes required for transport of these materials across the numerous extracellular and intracellular barriers are poorly understood. Efficient delivery of siRNA-containing nanoparticles would ultimately benefit from an improved understanding of how parameters associated with these barriers relate to the physicochemical properties of the nanoparticle vectors. We report the synthesis of three Pluronic (R)-based, cholesterol end capped cationic polyrotaxanes (PR+) threaded with 2-hydroxypropyl-beta-cyclodextrin (HP beta CD) for siRNA delivery. The biological data showed that PR+:siRNA complexes were well tolerated (similar to 90% cell viability) and produced efficient silencing (>80%) in HeLa-GFP and NIH 3T3-GFP cell lines. We further used a multi parametric approach to identify relationships between the PR+ structure, PR+:siRNA complex physical properties, and biological activity. Small angle X-ray scattering and cryoelectron microscopy studies reveal periodicity and lamellar architectures for PR+:siRNA complexes, whereas the biological assays, zeta potential measurements, and imaging studies suggest that silencing efficiency is influenced by the effective charge ratio (rho(eff)), polypropylene oxide (PO) block length, and central PO block coverage (i.e., rigidity) of the PR+ core. We infer from our findings that more compact PR+:siRNA nanostructures arising from lower molecular weight, rigid rod-like PR+ polymer cores produce improved silencing efficiency relative to higher molecular weight, more flexible PR+ vectors of similar effective charge. This study demonstrates that PR+:siRNA complex formulations can be produced having higher performance than Lipofectamine (R) 2000, while maintaining good cell viability and siRNA sequence protection in cell culture. (C) 2015 Elsevier Ltd. All rights reserved.